ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Mankind Pharma has allotted 49,112 equity shares under its ESOP Plan 2022 to eligible employees upon exercise of options. The allotment increases its paid-up share capital.
Mankind Pharma has allotted 49,112 equity shares under its ESOP scheme. This allotment increases the paid-up share capital by Rs. 49,112 in face value.
Mankind Pharma allotted 86,778 equity shares under its ESOP scheme. This increases the total paid-up share capital to 412,995,978 equity shares.
Mankind Pharma allotted 86,778 equity shares worth ₹7.50 Crore under its 2022 ESOP Plan. The allotment increases the company's total paid-up equity share capital.
Mankind Pharma allotted 80,872 equity shares under its employee stock option scheme. Post-allotment, the company's paid-up share capital increased to 412,909,200 equity shares.
Mankind Pharma allotted 80,872 equity shares worth ₹7.51 Crore under its ESOP 2022 plan. This exercise increases the company's paid-up share capital to 41,29,09,200 shares.